C57BL/6JCya-Men1em1/Cya
Common Name:
Men1-KO
Product ID:
S-KO-15795
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Men1-KO
Strain ID
KOCMP-17283-Men1-B6J-VA
Gene Name
Product ID
S-KO-15795
Gene Alias
-
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
19
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Men1em1/Cya mice (Catalog S-KO-15795) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000056391
NCBI RefSeq
NM_008583
Target Region
Exon 2~5
Size of Effective Region
~1.5 kb
Detailed Document
Overview of Gene Research
Men1, encoding a 610-amino acid protein menin, is a tumor suppressor gene [1]. Mutations in Men1 lead to multiple endocrine neoplasia type 1 (MEN1), an autosomal dominant disorder. Menin interacts with transcription factors and chromatin-modifying proteins in cell signaling pathways such as transforming growth factor β/bone morphogenetic protein, Wnt/β-catenin, and Hedgehog, facilitating the understanding of MEN1-associated tumor pathogenesis [3].
Mouse models of MEN1, with loss-of-function mutations in the Men1 gene, closely resemble the human disease in terms of tumor spectrum and hormonal changes [4]. These models have been exploited for therapy-response studies testing novel drugs against neuroendocrine tumors (NETs), providing promising leads for treating MEN1-related NENs [2,4]. They help understand the function of Menin in tumorigenesis, which is conserved from flies to mammals [4].
In conclusion, Men1 plays a crucial role in preventing the development of endocrine tumors as a tumor suppressor gene. The Men1-knockout mouse models have significantly contributed to the understanding of MEN1-associated tumor biology and the exploration of potential therapies for treating MEN1-related diseases, especially neuroendocrine neoplasms [2,4].
References:
1. Thakker, Rajesh V, Newey, Paul J, Walls, Gerard V, Tonelli, Francesco, Brandi, Maria Luisa. 2012. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). In The Journal of clinical endocrinology and metabolism, 97, 2990-3011. doi:10.1210/jc.2012-1230. https://pubmed.ncbi.nlm.nih.gov/22723327/
2. Grozinsky-Glasberg, Simona, Lines, Kate E, Avniel-Polak, Shani, Bountra, Chas, Thakker, Rajesh V. . Preclinical drug studies in MEN1-related neuroendocrine neoplasms (MEN1-NENs). In Endocrine-related cancer, 27, R345-R355. doi:10.1530/ERC-20-0127. https://pubmed.ncbi.nlm.nih.gov/32590358/
3. Brandi, Maria Luisa, Agarwal, Sunita K, Perrier, Nancy D, Valk, Gerlof D, Thakker, Rajesh V. . Multiple Endocrine Neoplasia Type 1: Latest Insights. In Endocrine reviews, 42, 133-170. doi:10.1210/endrev/bnaa031. https://pubmed.ncbi.nlm.nih.gov/33249439/
4. Mohr, Hermine, Pellegata, Natalia S. 2017. Animal models of MEN1. In Endocrine-related cancer, 24, T161-T177. doi:10.1530/ERC-17-0249. https://pubmed.ncbi.nlm.nih.gov/28743793/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen